Alzheimer's Drug Discovery Foundation (ADDF): Accelerating Drug Discovery for Frontotemporal Degeneration RFP (LOI)

About and Services

12/05/2025

Alzheimer’s Drug Discovery Foundation (ADDF): Accelerating Drug Discovery for Frontotemporal Degeneration RFP (LOI)

Description:

This RFP supports innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy) drug development programs for frontotemporal dementia (FTD).

Funding: Up to $350,000 over one year.

LEARN MORE

https://www.alzdiscovery.org/research-and-grants/funding-opportunities

Fields :

Life Sciences

Source :

Foreign